Clinical Trial Update: A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation study evaluating the combination of Trastuzumab Emtansine (T-DM1) with Neratinib in women with metastatic HER2-positive breast cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)
• neratinib (neratinib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-01-26